Association between Cholesterol Exposure and Neuropathological Findings: The ACT Study

Area of Science:

• Neurology
• Gerontology
• Cardiovascular Health

Background:

• Cholesterol's role in aging brain health is complex.
• Understanding late-life cholesterol's impact on neurodegeneration is crucial for preventative strategies.

Purpose of the Study:

• To investigate the association between late-life cholesterol exposure and specific neuropathological outcomes.
• To examine relationships with Alzheimer's disease, cerebral amyloid angiopathy, vascular brain injury, and Lewy body disease.

Main Methods:

• Utilized data from the Adult Changes in Thought (ACT) cohort study.
• Analyzed late-life HDL and total cholesterol levels, calculating non-HDL cholesterol.
• Employed linear mixed models and logistic regression, controlling for relevant covariates.

Main Results:

• No significant associations were found between late-life cholesterol and Alzheimer's disease neuropathology, amyloid angiopathy, or vascular brain injury.
• An association was observed between predicted non-HDL cholesterol at age 70 and Lewy body disease.
• No associations were found with Braak stage or CERAD score.

Conclusions:

• Late-life non-HDL cholesterol exposure may be associated with Lewy body disease.
• Further research is needed to elucidate the specific mechanisms linking cholesterol metabolism and Lewy body disease.